- Home
- ORKA vs ZYBT Comparison
ORKA vs ZYBT Comparison
Compare ORKA & ZYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- ZYBT
- Stock Information
- Founded
- ORKA 2004
- ZYBT 2004
- Country
- ORKA United States
- ZYBT China
- Employees
- ORKA N/A
- ZYBT N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ZYBT
- Sector
- ORKA Health Care
- ZYBT
- Exchange
- ORKA Nasdaq
- ZYBT NYSE
- Market Cap
- ORKA 354.2M
- ZYBT 340.3M
- IPO Year
- ORKA N/A
- ZYBT 2025
- Fundamental
- Price
- ORKA $14.21
- ZYBT $5.88
- Analyst Decision
- ORKA Strong Buy
- ZYBT
- Analyst Count
- ORKA 8
- ZYBT 0
- Target Price
- ORKA $39.71
- ZYBT N/A
- AVG Volume (30 Days)
- ORKA 360.1K
- ZYBT 280.2K
- Earning Date
- ORKA 08-15-2025
- ZYBT 07-03-2025
- Dividend Yield
- ORKA N/A
- ZYBT N/A
- EPS Growth
- ORKA N/A
- ZYBT N/A
- EPS
- ORKA N/A
- ZYBT 0.03
- Revenue
- ORKA N/A
- ZYBT $25,531,367.00
- Revenue This Year
- ORKA N/A
- ZYBT N/A
- Revenue Next Year
- ORKA N/A
- ZYBT N/A
- P/E Ratio
- ORKA N/A
- ZYBT $197.44
- Revenue Growth
- ORKA N/A
- ZYBT N/A
- 52 Week Low
- ORKA $5.49
- ZYBT $3.50
- 52 Week High
- ORKA $52.32
- ZYBT $14.30
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- ZYBT N/A
- Support Level
- ORKA N/A
- ZYBT N/A
- Resistance Level
- ORKA N/A
- ZYBT N/A
- Average True Range (ATR)
- ORKA 0.00
- ZYBT 0.00
- MACD
- ORKA 0.00
- ZYBT 0.00
- Stochastic Oscillator
- ORKA 0.00
- ZYBT 0.00
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About ZYBT ZHENGYE BIOTECHNOLOGY HLDG LTD
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.